CAXTON CORP
Follow13F filer, CIK 1388551, Princeton, NJ
CAXTON CORP reported $1,853,427 across 10 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-26-005174
Changes against Q1 2026 are not shown: its report omitted holdings under a confidential treatment request (7 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2026-06-30
- Reported value
- $1.85M
- Holdings
- 10
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0000919574-26-005174, largest first. % of portfolio is the value over $1,853,427, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SPCXSPACE EXPLORATION TECHN CORP | 2,606 | $445K | 24.03% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BRK-BBERKSHIRE HATHAWAY INC DEL | 754 | $377K | 20.35% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| GOOGLALPHABET INC | 691 | $247K | 13.32% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| VOOVANGUARD INDEX FDS | 339 | $233K | 12.58% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BXBLACKSTONE INC | 1,597 | $188K | 10.16% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| KYTXKYVERNA THERAPEUTICS INC | 12,347 | $110K | 5.94% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| LXEOLEXEO THERAPEUTICS INC | 16,962 | $79K | 4.26% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| XFORX4 PHARMACEUTICALS INC | 15,557 | $72.7K | 3.92% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| IKTINHIBIKASE THERAPEUTICS INC | 28,453 | $57.8K | 3.12% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| ALXOALX ONCOLOGY HLDGS INC | 20,946 | $43.4K | 2.34% | The filing omitted confidential holdings, a later amendment may add them. | Timeline |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-26-005174 | base | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-26-005174 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000919574-26-003017 | Quarter ended 2026-03-31 | 2026-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000919574-13-004916 | Quarter ended 2013-06-30 | 2013-08-14 | acceptance time not in the bulk data set |